Brachytherapy in the treatment of cervical cancer: A review

International Journal of Women's Health

Volumn 6, Issue 1, 2014, Pages 555-564

  Banerjee, Robyn ^a   Kamrava, Mitchell ^b  

^a TOM BAKER CANCER CENTRE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brachytherapy; Cervical cancer; Image guided brachytherapy

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE GUIDED RADIOTHERAPY; IMAGING AND DISPLAY; INTERSTITIAL BRACHYTHERAPY; INTRACAVITARY BRACHYTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; RADIATION APPLICATOR; RADIATION DOSE; RECTUM DISEASE; RECTUM TOXICITY; REVIEW; RISK ASSESSMENT; THREE DIMENSIONAL IMAGING; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT PLANNING; TWO DIMENSIONAL IMAGING; UTERINE CERVIX CANCER;

EID: 84901651675     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S46247     Document Type: Review

References (77)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137-2150.
3. Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997;8(5):755-763.
4. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002;347(21): 1645-1651.
5. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet. 2001;358(9284):781-786.
6. NCCN clinical practice guidelines in oncology: Cervical cancer [Internet]. 2011 [cited February 27, 2011]. National Comprehensive Cancer Network. Available from: http://www.nccn.org.
7. Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys. 1991;20(4):667-676.
8. Hanks GE, Herring DF, Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer. 1983; 51(5):959-967.
9. Coia L, Won M, Lanciano R, Marcial VA, Martz K, Hanks G. The patterns of care outcome study for cancer of the uterine cervix. Results of the second national practice survey. Cancer. 1990;66(12):2451-2456.
10. Montana GS, Martz KL, Hanks GE. Patterns and sites of failure in cervix cancer treated in the USA in 1978. Int J Radiat Oncol Biol Phys. 1991;20(1):87-93.
11. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43(4):763-775.
12. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235-245.
13. Sala E, Wakely S, Senior E, Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol. 2007;188(6): 1577-1587.
14. Kapur T, Egger J, Damato A, Schmidt EJ, Viswanathan AN. 3-T MR-guided brachytherapy for gynecologic malignancies. Magn Reson Imaging. 2012;30(9):1279-1290.
15. Hricak H, Gatsonis C, Coakley FV, et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology. 2007;245(2):491-498.
16. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: Comparison of MR imaging and surgical findings. Radiology. 1988;166(3):623-631.
17. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT. Radiology. 2006;238(1):272-279.
18. Kidd EA, Siegel BA, Dehdashti F, et al. Lymph node staging by positron emission tomography in cervical cancer: Relationship to prognosis. J Clin Oncol. 2010;28(12):2108-2113.
19. Viswanathan AN, Thomadsen B; American Brachytherapy Society Cervical Cancer Recommendations Committee, American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. part I: General principles. Brachytherapy. 2012;11(1):33-46.
20. Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys. 1993;27(5):1051-1056.
21. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;32(5):1275-1288.
22. Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 1995;32(5):1301-1307.
23. Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys. 1993;25(3):391-397.
24. Viswanathan AN, Erickson BA. Three-dimensional imaging in gynecologic brachytherapy: A survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2010;76(1):104-109.
25. Wang X, Liu R, Ma B, Yang K, Tian J, Jiang L, et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev. 2010;(7):CD007563.
26. Demanes DJ, Rodriguez RR, Bendre DD, Ewing TL. High dose rate transperineal interstitial brachytherapy for cervical cancer: High pelvic control and low complication rates. Int J Radiat Oncol Biol Phys. 1999;45(1):105-112.
27. Park HC, Suh CO, Kim GE. Fractionated high-dose-rate brachytherapy in the management of uterine cervical cancer. Yonsei Med J. 2002;43(6): 737-748.
28. Brenner DJ, Hall EJ. Fractionated high dose rate versus low dose rate regimens for intracavitary brachytherapy of the cervix. I. general considerations based on radiobiology. Br J Radiol. 1991;64(758): 133-141.
29. Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1991;20(1):181-190.
30. Viswanathan AN, Creutzberg CL, Craighead P, et al. International brachytherapy practice patterns: A survey of the gynecologic cancer intergroup (GCIG). Int J Radiat Oncol Biol Phys. 2012;82(1): 250-255.
31. Dimopoulos JC, Kirisits C, Petric P, et al. The vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys. 2006;66(1):83-90.
32. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Potter R. The vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;65(2):624-630.
33. Smit BJ, van Wijk AL. An improved, disposable indwelling intrauterine tube ("smit sleeve") not requiring retaining stitches for brachy-radiotherapy for carcinoma of the cervix. Eur J Gynaecol Oncol. 2013;34(4):289-290.
34. Smit BJ, du Toit JP, Groenewald WA. An indwelling intrauterine tube to facilitate intracavitary radiotherapy of carcinoma of the cervix. Br J Radiol. 1989;62(733):68-69.
35. Erickson B, Foley W, Gillin M. Ultrasound-guided transperineal interstitial implantation of pelvic malignancies: Description of the technique. Endocurie Hypertherm Oncol. 1995;11:107-113.
36. Welliver M, Lin L. Evaluation of a balloon-based vaginal packing system and patient-controlled analgesia for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. Practical Radiation Oncology. 2012;3(4):263-268.
37. Viswanathan AN, Moughan J, Small W, et al. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer. 2012;22(1):123-131.
38. Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): A patterns of care study. Int J Radiat Oncol Biol Phys. 2005;63(4):1083-1092.
39. Corn BW, Hanlon AL, Pajak TF, Owen J, Hanks GE. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol. 1994;53(3):294-300.
40. Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013;87(1):111-119.
41. International Commission of Radiation Units and Measurements. Dose and Volume Specification for Reporting Intracavitary Therapy in Gynaecology. Bethesda, MD: ICRU; 1985. Report No: 38.
42. Potish R, Gerbi B, Engler G. Dose Prescription, Dose Specification, and Applicator Geometry in Intracavitary Therapy. Madison, WI: Medical Physics Publishing; 1995.
43. Tod M, Meredith WJ. Treatment of cancer of the cervix uteri, a revised manchester method. Br J Radiol. 1953;26(305):252-257.
44. Potter R, Kirisits C, Fidarova EF, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol. 2008;47(7):1325-1336.
45. Narayan K, Barkati M, van Dyk S, Bernshaw D. Image-guided brachytherapy for cervix cancer: From Manchester to Melbourne. Expert Rev Anticancer Ther. 2010;10(1):41-46.
46. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62(1):131-137.
47. Potter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67-77.
48. Hellebust TP, Kirisits C, Berger D, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol. 2010;96(2):153-160.
49. Dimopoulos JC, Petrow P, Tanderup K, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012;103(1):113-122.
50. Rownd J, Erickson B. USA: Medical College of Wisconsin, Milwaukee. In: Viswanathan A, Kirisitis C, Erickson Bea, editors. Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management. New York: Springer; 2011:231-238.
51. Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Potter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68(2):491-498.
52. American Brachytherapy Society: Brachytherapy Guidelines [Internet]. 2014 [cited November 1, 2013]. Reston, VA: American Brachytherapy Society. Available from: http://www.americanbrachytherapy.org/guidelines/index.cfm.
53. Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. part II: High-dose-rate brachytherapy. Brachytherapy. 2012;11(1):47-52.
54. Sharma DN, Rath GK, Thulkar S, Kumar S, Subramani V, Julka PK. High-dose rate interstitial brachytherapy using two weekly sessions of 10 gy each for patients with locally advanced cervical carcinoma. Brachytherapy. 2011;10(3):242-248.
55. Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 1991;21(6):1425-1434.
56. Huang EY, Sun LM, Lin H, et al. A prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013;85(1):123-128.
57. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 1999;43(2):359-366.
58. Toita T, Kakinohana Y, Ogawa K, et al. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys. 2003;56(5):1344-1353.
59. Georg P, Lang S, Dimopoulos JC, et al. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 1 2011;79(2):356-362.
60. Potter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100(1): 116-123.
61. Charra-Brunaud C, Levitchi M, Delannes M. Dosimetric. Clinical results of a french prospective study of 3D brachytherapy for cervix carcinoma. Radiother Oncol. 2011;99(S57).
62. Dimopoulos JC, Potter R, Lang S, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol. 2009;93(2):311-315.
63. Tanderup K, Fokdal L, Sturdza A, et al. Dose-response for local control in image guided cervix brachytherapy in the retroEMBRACE study. Paper presented at ESTRO 2013; April 19-23, 2013; Geneva, Switzerland.
64. Pinn-Bingham M, Puthawala AA, Syed AM, et al. Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: Long-term results. Int J Radiat Oncol Biol Phys. 2013;85(3):714-20.
65. Perez CA, Breaux S, Bedwinek JM, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. analysis of complications. Cancer. 1984;54(2):235-246.
66. Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999;44(4):855-866.
67. Barillot I, Horiot JC, Maingon P, et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies. Int J Radiat Oncol Biol Phys. 2000;48(1):189-200.
68. Clark BG, Souhami L, Roman TN, Chappell R, Evans MD, Fowler JF. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1997;38(5):989-993.
69. Chen SW, Liang JA, Yang SN, Liu RT, Lin FJ. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;47(4):955-961.
70. Georg P, Kirisits C, Goldner G, et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol. 2009;91(2):173-180.
71. Koom WS, Sohn DK, Kim JY, et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys. 2007;68(5):1446-1454.
72. Georg P, Potter R, Georg D, et al. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2012;82(2):653-657.
73. Lee LJ, Viswanathan AN. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Int J Radiat Oncol Biol Phys. 2012;84(5):1192-1197.
74. Sethi RA, Jozsef G, Grew D, et al. Is there a role for an external beam boost in cervical cancer radiotherapy? Front Oncol. 2013;3:3.
75. Hsieh CH, Wei MC, Hsu YP, et al. Should helical tomotherapy replace brachytherapy for cervical cancer? Case Report. BMC Cancer. 2010;10:637.
76. Marnitz S, Kohler C, Budach V, et al. Robotic radiosurgery: Emulating brachytherapy in patients with locally advanced cervical carcinoma. Technique, feasibility and acute toxicity. Radiat Oncol. 2013;8(1):109.
77. Haas JA, Witten MR, Clancey O, Episcopia K, Accordino D, Chalas E. CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy. Front Oncol. 2012;2:25.